Evidence map›Paper›PMID 27082727›Full record

ArticleAmerican journal of respiratory cell and molecular biology2016

Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for Alveolarization.

Manuela Funke, Lars Knudsen, David Lagares, Simone Ebener, Clemens K Probst, Benjamin A Fontaine, Alicia Franklin, Manuela Kellner, Mark Kühnel, Stephanie Matthieu and 5 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Stereology as the 3D tool to quantitate lung architecture.Histochemistry and cell biology · 2021
    Review
  5. Lysophospholipids in Lung Inflammatory Diseases.Advances in experimental medicine and biology · 2021
    Article
  6. Review
  7. Review
  8. Review
  9. Fra-2 negatively regulates postnatal alveolar septation by modulating myofibroblast function.American journal of physiology. Lung cellular and molecular physiology · 2017
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Manuela Funke1 Departments of Pulmonary Medicine, Inselspital Berne, and.
Lars Knudsen4 Institute of Functional and Applied Anatomy, Hannover Medical School, and Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, REBIRTH Cluster of Excellence, Hannover, Germany; and.
David Lagares3 Division of Pulmonary and Critical Care Medicine and Center for Immunology and Inflammatory Diseases, and.
Simone Ebener1 Departments of Pulmonary Medicine, Inselspital Berne, and.
Clemens K Probst3 Division of Pulmonary and Critical Care Medicine and Center for Immunology and Inflammatory Diseases, and.
Benjamin A Fontaine3 Division of Pulmonary and Critical Care Medicine and Center for Immunology and Inflammatory Diseases, and.
Alicia Franklin3 Division of Pulmonary and Critical Care Medicine and Center for Immunology and Inflammatory Diseases, and.
Manuela Kellner4 Institute of Functional and Applied Anatomy, Hannover Medical School, and Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, REBIRTH Cluster of Excellence, Hannover, Germany; and.
Mark Kühnel4 Institute of Functional and Applied Anatomy, Hannover Medical School, and Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, REBIRTH Cluster of Excellence, Hannover, Germany; and.
Stephanie Matthieu4 Institute of Functional and Applied Anatomy, Hannover Medical School, and Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, REBIRTH Cluster of Excellence, Hannover, Germany; and.
Roman Grothausmann4 Institute of Functional and Applied Anatomy, Hannover Medical School, and Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, REBIRTH Cluster of Excellence, Hannover, Germany; and.
Jerold Chun5 Department of Molecular and Cellular Neuroscience, Dorris Neuroscience Center, Scripps Research Institute, La Jolla, California.
Jesse D Roberts6 Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Matthias Ochs4 Institute of Functional and Applied Anatomy, Hannover Medical School, and Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, REBIRTH Cluster of Excellence, Hannover, Germany; and.
Andrew M Tager3 Division of Pulmonary and Critical Care Medicine and Center for Immunology and Inflammatory Diseases, and.
Medizinische Hochschule Hannover · DEPulmonary and Critical Care Associates · USUniversity of Bern · CHHarvard University · USScripps Research Institute · US

Funding

Prenatal blood-borne lipids in post-hemorrhagic hydrocephalusR01NS084398 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI CHUN, JEROLD · 2014 to 2017
$2.6M
Protective Role of the S1P-S1P1 Pathway in Pulmonary FibrosisR01HL108975 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI TAGER, ANDREW M · 2011 to 2015
$1.8M
TGFB and Nitric Oxide Signaling in Pediatric Pulmonary Vascular DiseaseR01HL125715 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROBERTS, JESSE D · 2015 to 2018
$1.7M
The LPA Pathway in Lung Fibrosis: Novel Mediators and New Therapeutic TargetsR01HL095732 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI TAGER, ANDREW M · 2009 to 2010
$922k
NHLBI NIH HHS R01 HL095732NHLBI NIH HHS R01 HL108975NHLBI NIH HHS R01 HL125715NINDS NIH HHS R01 NS084398
6 · The paper itself

Abstract

Lysophosphatidic acid (LPA) signaling through one of its receptors, LPA1, contributes to both the development and the pathological remodeling after injury of many organs. Because we found previously that LPA-LPA1 signaling contributes to pulmonary fibrosis, here we investigated whether this pathway is also involved in lung development. Quantitative assessment of lung architecture of LPA1-deficient knock-out (KO) and wild-type (WT) mice at 3, 12, and 24 weeks of age using design-based stereology suggested the presence of an alveolarization defect in LPA1 KO mice at 3 weeks, which persisted as alveolar numbers increased in WT mice into adulthood. Across the ages examined, the lungs of LPA1 KO mice exhibited decreased alveolar numbers, septal tissue volumes, and surface areas, and increased volumes of the distal airspaces. Elastic fibers, critical to the development of alveolar septa, appeared less organized and condensed and more discontinuous in KO alveoli starting at P4. Tropoelastin messenger RNA expression was decreased in KO lungs, whereas expression of matrix metalloproteinases degrading elastic fibers was either decreased or unchanged. These results are consistent with the abnormal lung phenotype of LPA1 KO mice, being attributable to reduced alveolar septal formation during development, rather than to increased septal destruction as occurs in the emphysema of chronic obstructive pulmonary disease. Peripheral septal fibroblasts and myofibroblasts, which direct septation in late alveolarization, demonstrated reduced production of tropoelastin and matrix metalloproteinases, and diminished LPA-induced migration, when isolated from LPA1 KO mice. Taken together, our data suggest that LPA-LPA1 signaling is critically required for septation during alveolarization.

Indexed as

MorphogenesisSignal TransductionAnimalsCell CountCell MovementCell SizeElasticityElastinExtracellular MatrixFibroblastsLysophospholipidsMatrix MetalloproteinasesMice, Inbred C57BLMice, KnockoutPulmonary AlveoliReceptors, Lysophosphatidic AcidElastinlysophosphatidic acidLysophospholipidsMatrix MetalloproteinasesReceptors, Lysophosphatidic AcidTissue Inhibitor of MetalloproteinasesTropoelastinalveolarizationelastinLPA1lung developmentmatrix metalloproteinase

Identifiers

PMID27082727
PMCPMC4942205
OpenAlexW2253898465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.